Objective: To study the effect of raloxifene on endometrialhistopathology of menopausal women. Methods: Thirty-one patientsunder raloxifene treatment (60 mg/day) for a six-month periodand submitted to diagnostic videohysteroscopy at the ClimatericOutpatients Clinic, Department of Gynecology and Obstetrics,Hospital do Servidor Público Estadual Francisco Morato de Oliveira,in the city of São Paulo, and at Hospital Guilherme Álvaro, in thecity of Santos, from September 10th, 2003 to June 22nd, 2004, wereanalyzed. Guided endometrial biopsy was performed on all patientson the anterior wall, using a 3-mm or 5-mm biopsy forceps. A 3-mmor 5-mm hysteroscope was used with TV imaging by an endocamera.The results of the hysteroscopic tests were compare...
Objective: To evaluate the effects after 10 days of an original treatment combining oral progestins ...
OBJECTIVES: To review the main findings of the Euralox 1 study - a multicentre, randomised, double-b...
Study Objective. To evaluate hysteroscopic endometrial changes due to tamoxifen therapy in postmenop...
Objective: the aim of this study was to summarize the evidence of endometrial safety and quality of ...
Introdução: O uso da terapia estrogenica associada aos progestagenios parece aumentar os riscos de d...
Objective: To evaluate by hysteroscopy and histopathology the influence of tamoxifen in the endometr...
Objective: To compare the uterine effects of 60 mg of raloxifene with a continuous combined hormone ...
Objective: The objective was to analyze the effect of raloxifene oil the vaginal epithelium of postm...
Objective: The aim of this study was to evaluate the effect of tamoxifen on the endometrium of post-...
Objective: To evaluate the effects of raloxifene administration on uterine and uterine leiomyoma siz...
OBJECTIVE: To evaluate whether 6 months of raloxifene was effective in treatment of chronic pelvic p...
OBJECTIVE: To compare ospemifene and raloxifene regarding their effects on hormones, lipids, genital...
OBJECTIVE To determine if there is any enhancement of e⁄cacy with the addition of raloxifene to gona...
Study Objective. To evaluate hysteroscopic endometrial changes due to tamoxifen therapy in postmenop...
To evaluate all the in-vitro raloxifene (RAL) mechanisms of action on normal, Ishikawa, and differen...
Objective: To evaluate the effects after 10 days of an original treatment combining oral progestins ...
OBJECTIVES: To review the main findings of the Euralox 1 study - a multicentre, randomised, double-b...
Study Objective. To evaluate hysteroscopic endometrial changes due to tamoxifen therapy in postmenop...
Objective: the aim of this study was to summarize the evidence of endometrial safety and quality of ...
Introdução: O uso da terapia estrogenica associada aos progestagenios parece aumentar os riscos de d...
Objective: To evaluate by hysteroscopy and histopathology the influence of tamoxifen in the endometr...
Objective: To compare the uterine effects of 60 mg of raloxifene with a continuous combined hormone ...
Objective: The objective was to analyze the effect of raloxifene oil the vaginal epithelium of postm...
Objective: The aim of this study was to evaluate the effect of tamoxifen on the endometrium of post-...
Objective: To evaluate the effects of raloxifene administration on uterine and uterine leiomyoma siz...
OBJECTIVE: To evaluate whether 6 months of raloxifene was effective in treatment of chronic pelvic p...
OBJECTIVE: To compare ospemifene and raloxifene regarding their effects on hormones, lipids, genital...
OBJECTIVE To determine if there is any enhancement of e⁄cacy with the addition of raloxifene to gona...
Study Objective. To evaluate hysteroscopic endometrial changes due to tamoxifen therapy in postmenop...
To evaluate all the in-vitro raloxifene (RAL) mechanisms of action on normal, Ishikawa, and differen...
Objective: To evaluate the effects after 10 days of an original treatment combining oral progestins ...
OBJECTIVES: To review the main findings of the Euralox 1 study - a multicentre, randomised, double-b...
Study Objective. To evaluate hysteroscopic endometrial changes due to tamoxifen therapy in postmenop...